HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Li-ming Tan Selected Research

antithrombin Cambridge II

9/2010Antithrombin Cambridge II(A384S) mutation frequency and antithrombin activity levels in 120 of deep venous thrombosis and 150 of cerebral infarction patients in a single center in Southern China.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Li-ming Tan Research Topics

Disease

2Disease Progression
05/2015 - 04/2012
2Cerebral Infarction
09/2010 - 10/2005
1Thrombophilia
09/2010
1Venous Thrombosis (Deep-Vein Thrombosis)
09/2010
1Hepatitis
06/2006
1Infections
10/2005
1Machado-Joseph Disease (Spinocerebellar Ataxia Type 3)
06/2005

Drug/Important Bio-Agent (IBA)

2Proteins (Proteins, Gene)FDA Link
05/2015 - 06/2005
1Biomarkers (Surrogate Marker)IBA
04/2012
1antithrombin Cambridge IIIBA
09/2010
1AntithrombinsIBA
09/2010
1AntibodiesIBA
06/2006
1Atorvastatin (Lipitor)FDA Link
10/2005
1Interleukin-6 (Interleukin 6)IBA
10/2005
1LipidsIBA
10/2005
1C-Reactive ProteinIBA
10/2005
1Ataxin-3IBA
06/2005